Transgene Biotek
Reg. 32(1) Statement Of Deviation & Variation.
Original release on Moneycontrol
Earlier from Transgene Biotek
- Compliance-57 (5): intimation after the end of quarter
- Compliance-57 (4): Prior intimation to the beginning of the quarter
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018